MedPath

福建广生中霖生物科技有限公司

Ownership
-
Established
2021-11-22
Employees
-
Market Cap
-
Website
www.akeylink.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Ritonavir Tablets

Product Name
利托那韦片
Approval Number
国药准字H20254135
Approval Date
May 13, 2025
NMPA

Atilotrelvir Tablets/Ritonavir Tablets(co-packaged)

Product Name
泰中定
Approval Number
国药准字H20230029
Approval Date
Nov 23, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.